0001140361-11-036013.txt : 20110706 0001140361-11-036013.hdr.sgml : 20110706 20110706193139 ACCESSION NUMBER: 0001140361-11-036013 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20110701 FILED AS OF DATE: 20110706 DATE AS OF CHANGE: 20110706 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: FUCHS HENRY J CENTRAL INDEX KEY: 0001197355 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-26727 FILM NUMBER: 11954704 MAIL ADDRESS: STREET 1: C/O INTRABIOTICS PHARMACEUTICALS INC STREET 2: 1245 TERRA BELLA AVENUE CITY: MOUNTAIN VIEW STATE: CA ZIP: 94043 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOMARIN PHARMACEUTICAL INC CENTRAL INDEX KEY: 0001048477 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 680397820 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 105 DIGITAL DRIVE CITY: NOVATO STATE: CA ZIP: 94949 BUSINESS PHONE: 4155066700 MAIL ADDRESS: STREET 1: 105 DIGITAL DRIVE CITY: NOVATO STATE: CA ZIP: 94949 4 1 doc1.xml FORM 4 X0303 4 2011-07-01 0 0001048477 BIOMARIN PHARMACEUTICAL INC BMRN 0001197355 FUCHS HENRY J C/O BIOMARIN PHARMACEUTICAL INC. 105 DIGITAL DRIVE NOVATO CA 94949 0 1 0 0 EVP, Chief Medical Officer Common Stock 2011-07-01 2011-07-01 4 M 0 2500 11.05 A 38955 D Common Stock 2011-07-01 2011-07-01 4 S 0 2500 27.68 D 36455 D Stock Option (right to buy) 11.05 2011-07-01 2011-07-01 4 M 0 2500 0 D 2009-09-02 2019-03-01 Common Stock 2500 296000 D Transaction made pursuant to a Rule 10b5-1 Trading plan executed on March 9, 2011. The range of sales prices received was $27.15 to $27.85. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information will be provided regarding the number of shares purchased or sold at each separate price. Original option grant vests 6/48ths on September 2, 2009 and 1/48th on the 2nd of each month thereafter. /s/ Laura Randall Woodhead, Attorney-in-Fact 2011-07-06